ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
141 hedge funds and large institutions have $829M invested in Achillion Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 62 increasing their positions, 38 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
141
Holders Change
-17
Holders Change %
-10.76%
% of All Funds
3.94%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
16
Increased
62
Reduced
38
Closed
33
Calls
$27.3M
Puts
$13M
Net Calls
+$14.3M
Net Calls Change
-$4.57M
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$36.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$26.6M |
| 3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$12.4M |
| 4 |
DM
Deerfield Management
New York
|
+$11.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$9.56M |
Top Sellers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$23.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15.3M |
| 3 |
Stifel Financial
St. Louis,
Missouri
|
-$5.12M |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$4.43M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$3.37M |
